Answers are grounded in this paper and cite their sources.
BACKGROUND Peritoneal dialysis represents one of the primary alternative therapies for end-stage renal disease. Peritoneal fibrosis (PF) may, however, develop as a consequence of the peritoneum being exposed to non-physiological peritoneal dialysis fluid over extended durations. PF is the main factor that forces end-stage renal disease patients to discontinue long-term peritoneal dialysis. Therefore, how to delay and block the progression of PF has surfaced as an issue demanding timely scholarly attention. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have a reversing effect on the fibrosis levels of various tissues. We hypothesized that hUC-MSCs may afford protection in PF. AIM To investigate the modulatory potential of hUC-MSCs across both in vivo and in vitro experimental models of PF. METHODS Both the in vivo and in vitro PF models displayed differential expression of cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). Next, hUC-MSC-mediated effects on epithelial-mesenchymal transition (EMT) driven by high glucose (HG) in HMrSV5 cells were determined. We also performed a rescue experiment with the STING agonist DMXAA to validate the engagement of the cGAS-STING signaling cascade in this event. The anti-fibrotic potential of hUC-MSCs was lastly investigated in a mouse model of PF. RESULTS Heightened levels of cGAS and STING proteins were discernible in both HG-exposed HMrSV5 cells and the mouse PF model. The presence of hUC-MSCs in co-culture exerted a potent suppressive influence on HG-evoked migratory, invasive, and EMT-related molecular changes in HMrSV5 cells. DMXAA-mediated intervention nullified the protective capacity of hUC-MSCs against HG-occasioned EMT in HMrSV5 cells. In addition, hUC-MSC intervention in PF mice dually mitigates peritoneal fibrotic alterations and inflammatory infiltration while lowering the protein expression of cGAS-STING pathway components. CONCLUSION The cGAS-STING pathway is activated in PF models both in vivo and in vitro , hUC-MSCs inhibit this pathway to suppress EMT in HMrSV5 cells and retard PF progression in mice.
No takes yet. Share an insight, caveat, or question.
Fu-xing et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: